TradeSmith Snippets: Twitter Arbitrage Investors Prepare for a Payday, a Breakthrough Biotech IPO, and 3 Inflation-Resistant Stocks
So far, 2022 has offered the fewest IPOs since 2016. But there’s a company that’s about to go public with breakthrough DNA technology, which it believes has the potential to repair 90% of known disease-causing mutations.
Read now